State Street Corp Bio Affinity Technologies, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, State Street Corp holds 17,600 shares of BIAF stock, worth $23,408. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,600
Previous 17,600
-0.0%
Holding current value
$23,408
Previous $35,000
8.57%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
16Shares Held
376KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA172KShares$228,7520.0% of portfolio
-
Geode Capital Management, LLC Boston, MA69.6KShares$92,5680.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$37,0870.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny23KShares$30,5460.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC15KShares$19,9500.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $3.63M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...